Mystical Experience Questionaire 30 Item
The Mystical Experience Questionnaire Thirty (MEQ30) is a thirty item scale based on a longer Mystical Experience Questionaire developed by Panke.[1] The scale is based on the conceptual model provided by Stace.[2][3]
Measurement of Connection (mystical) Experience
Connection Experience > APZ (Abnormal Mental States) Questionnaire, Hood's Mysticism Scale, Mystical Experience Questionaire 30 Item, States of Consciousness Questonnaire
Notes
The MEQ30
REVISED MYSTICAL EXPERIENCE QUESTIONNAIRE[4]
(MEQ; 30 ITEMS )
Instructions: Looking back on the entirety of your psilocybin session, please rate the degree to which at any time during that session you experienced the following phenomena. Answer each question according to your feelings, thoughts, and experiences at the time of the psilocybin session. In making each of your ratings, use the following scale:
0 – none; not at all
1 – so slight cannot decide
2 – slight
3 – moderate
4 – strong (equivalent in degree to any other strong experience)
5 – extreme (more than any other time in my life and stronger than 4)
Factor 1: Mystical
Internal Unity
35. Freedom from the limitations of your personal self and feeling a unity or bond with
what was felt to be greater than your personal self.
41. Experience of pure being and pure awareness (beyond the world of sense
impressions).
54. Experience of oneness in relation to an “inner world” within.
77. Experience of the fusion of your personal self into a larger whole.
83. Experience of unity with ultimate reality.
12. Feeling that you experienced eternity or infinity.
External Unity
14. Experience of oneness or unity with objects and/or persons perceived in your
surroundings.
47. Experience of the insight that “all is One”.
74. Awareness of the life or living presence in all things.
Noetic Quality
9. Gain of insightful knowledge experienced at an intuitive level.
22. Certainty of encounter with ultimate reality (in the sense of being able to “know”
and “see” what is really real at some point during your experience.
69. You are convinced now, as you look back on your experience, that in it you
encountered ultimate reality (i.e., that you “knew” and “saw” what was really real).
Sacredness
36. Sense of being at a spiritual height.
55. Sense of reverence.
73. Feeling that you experienced something profoundly sacred and holy.
Factor 2: Positive Mood
5. Experience of amazement.
18. Feelings of tenderness and gentleness.
30. Feelings of peace and tranquility.
43. Experience of ecstasy.
80. Sense of awe or awesomeness.
87. Feelings of joy.
Factor 3: Transcendence of Time and Space
2. Loss of your usual sense of time.
15. Loss of your usual sense of space.
29. Loss of usual awareness of where you were.
34. Sense of being “outside of” time, beyond past and future.
48. Being in a realm with no space boundaries.
65. Experience of timelessness.
Factor 4: Ineffability
6. Sense that the experience cannot be described adequately in words.
23. Feeling that you could not do justice to your experience by describing it in words.
86. Feeling that it would be difficult to communicate your own experience to others
who have not had similar experiences.
Note: Item numbers correspond to item number within the original 100-item questionnaire.
Footnotes
- ↑ Pahnke, Walter N. “Drugs and Mysticism.” In The Highest State of Consciousness, edited by John White, 251–68. New York: Doubleday, 2012
- ↑ Stace, Walter Terence. Mysticism and Philosophy. London: Macmillan, 1960. https://wudhi.azurewebsites.net/mysticism/ws/wts-mp%20-%20index.htm
- ↑ Katherine A. Maclean, Mathew W. Johnson, Jeannie-Marie S. Leoutsakos, and Roland R. Griffiths. “Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.” Journal for the Scientific Study of Religion 51, no. 4 (2012): 721–37
- ↑ Katherine A. Maclean, Mathew W. Johnson, Jeannie-Marie S. Leoutsakos, and Roland R. Griffiths. “Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.” Journal for the Scientific Study of Religion 51, no. 4 (2012): 721–37
